| 1 |
Shum E, Stuart M, Borczuk A, et al. Recent advances in the management of pulmonary sarcomatoid carcinoma[J]. Expert Rev Respir Med, 2016, 10(4): 407-416.
|
| 2 |
Lococo F, Gandolfi G, Rossi G, et al. Deep sequencing analysis reveals that KRAS nutation is a marker of poor prognosis in patients with pulmonary sarcomatoid carcinoma[J]. J Thorac Oncol, 2016, 11(8): 1282-1292.
|
| 3 |
Fallet V, Saffroy R, Girard N, et al. High-throughput somatic mutation profiling in pulmonary sarcomatoid carcinomas using the LungCarta™ Panel: exploring therapeutic targets[J]. Ann Oncol, 2015, 26(8): 1748-1753.
|
| 4 |
Vieira T, Duruisseaux M, Ruppert AM, et al. Pulmonary sarcomatoid carcinoma[J]. Bull Cancer, 2012, 99(10): 995-1001.
|
| 5 |
Steuer Conor E, Behera Madhusmita, Yuan Liu, et al. Pulmonary sarcomatoid carcinoma: an analysis of the national cancer data base[J]. Clin Lung Cancer, 2017，18(3): 286-292.
|
| 6 |
Mochizuki T, Ishii G, Nagai K, et al. Pleomorphic carcinoma of the lung: clinicopathologic characteristics of 70 cases[J]. Am J Surg Pathol, 2008, 32(11): 1727-1735.
|
| 7 |
Sarcomatoid carcinoma of the lung: a clinicopathologic study of 37 cases[J]. Cancer, 1999, 86(4): 608-616.
|
| 8 |
Martin LW, Correa AM, Ordonez NG, et al. Sarcomatoid carcinoma of the lung: a predictor of poor prognosis[J]. Ann Thorac Surg, 2007, 84(3): 973-980.
|
| 9 |
Vieira T, Girard N, Ung M, et al. Efficacy of first-line chemotherapy in patients with advanced lung sarcomatoid carcinoma[J]. J Thorac Oncol, 2013, 8(12): 1574-1577.
|
| 10 |
Steuer CE, Behera M, Liu Y, et al. Pulmonary sarcomatoid carcinoma：an analysis of the national cancer data base[J]. Clin Lung Cancer, 2017, 18(3): 286-292.
|
| 11 |
Shiroyama T, Tanaka A, Tamiya M, et al. A rare case of pleomorphic carcinoma of the lung harboring an anaplastic lymphoma kinase (ALK) rearrangement[J]. Intern Med, 2015, 54: 2741-2743.
|
| 12 |
Murakami Y, Saka H, Oki M. Response to crizotinib and clinical outcome in ALK-rearranged pulmonary pleomorphic carcinoma[J]. J Thorac Oncol, 2015, 10: e28-e29.
|
| 13 |
Maruyama R, Matsumura F, Shibata Y, et al. Detection of ALK rearrangement in an octogenarian patient with pleomorphic carcinoma of the lung[J]. Gen Thorac Cardiovasc Surg, 2016, 64: 167-169.
|
| 14 |
Chen X, Zhang Y, Lu J, Xu C, et al. Pulmonary sarcomatoid carcinoma with ALK rearrangement: frequency, clinical-pathologic characteristics, and response to ALK inhibitor[J]．Transl Oncol, 2017, 10(2): 115-120.
|